CA79648/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1999	1
2000	2
2001	3
2002	1
2005	1
2006	4
2007	1
2008	2
2024	0

1

Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context.

Johnson DG, Degregori J. Johnson DG, et al. Curr Mol Med. 2006 Nov;6(7):731-8. doi: 10.2174/1566524010606070731. Curr Mol Med. 2006. PMID: 17100599 Review.

2

The paradox of E2F1: oncogene and tumor suppressor gene.

Johnson DG. Johnson DG. Mol Carcinog. 2000 Mar;27(3):151-7. doi: 10.1002/(sici)1098-2744(200003)27:3<151::aid-mc1>3.0.co;2-c. Mol Carcinog. 2000. PMID: 10708476

3

Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis.

DeGregori J, Johnson DG. DeGregori J, et al. Curr Mol Med. 2006 Nov;6(7):739-48. doi: 10.2174/1566524010606070739. Curr Mol Med. 2006. PMID: 17100600 Review.

4

E2F1 and E2F3 activate ATM through distinct mechanisms to promote E1A-induced apoptosis.

Hong S, Paulson QX, Johnson DG. Hong S, et al. Cell Cycle. 2008 Feb 1;7(3):391-400. doi: 10.4161/cc.7.3.5286. Epub 2007 Nov 6. Cell Cycle. 2008. PMID: 18235226

5

Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.

Wang D, Russell J, Xu H, Johnson DG. Wang D, et al. Mol Carcinog. 2001 Jun;31(2):90-100. doi: 10.1002/mc.1044. Mol Carcinog. 2001. PMID: 11429786

6

Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis.

Hong S, Pusapati RV, Powers JT, Johnson DG. Hong S, et al. Cell Cycle. 2006 Apr;5(8):801-3. doi: 10.4161/cc.5.8.2638. Epub 2006 Apr 17. Cell Cycle. 2006. PMID: 16582589

7

Regulation of BRCA1 expression by the Rb-E2F pathway.

Wang A, Schneider-Broussard R, Kumar AP, MacLeod MC, Johnson DG. Wang A, et al. J Biol Chem. 2000 Feb 11;275(6):4532-6. doi: 10.1074/jbc.275.6.4532. J Biol Chem. 2000. PMID: 10660629 Free article.

8

ARF differentially modulates apoptosis induced by E2F1 and Myc.

Russell JL, Powers JT, Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG. Russell JL, et al. Mol Cell Biol. 2002 Mar;22(5):1360-8. doi: 10.1128/MCB.22.5.1360-1368.2002. Mol Cell Biol. 2002. PMID: 11839803 Free PMC article.

9

Myc lacks E2F1's ability to suppress skin carcinogenesis.

Rounbehler RJ, Schneider-Broussard R, Conti CJ, Johnson DG. Rounbehler RJ, et al. Oncogene. 2001 Aug 30;20(38):5341-9. doi: 10.1038/sj.onc.1204691. Oncogene. 2001. PMID: 11536046

10

Transgenic expression of E2F3a causes DNA damage leading to ATM-dependent apoptosis.

Paulson QX, Pusapati RV, Hong S, Weaks RL, Conti CJ, Johnson DG. Paulson QX, et al. Oncogene. 2008 Aug 21;27(36):4954-61. doi: 10.1038/onc.2008.138. Epub 2008 May 12. Oncogene. 2008. PMID: 18469863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year